Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 03 2021
Historique:
entrez: 18 5 2021
pubmed: 19 5 2021
medline: 29 6 2021
Statut: ppublish

Résumé

To evaluate the association between ellipsoid zone (EZ) on spectral domain optical coherence tomography (SD-OCT) and visual acuity letter score (VALS) in participants with retinal vein occlusion in the Study of Comparative Treatments for Retinal Vein Occlusion 2. SD-OCT scans of 362 participants were qualitatively assessed at baseline and months 1, 6, 12, and 24 for EZ status as normal, patchy, or absent. The thickness of EZ layer in the central subfield was also obtained using machine learning. EZ assessments were not possible at baseline due to signal blockage in >75% of eyes. At month 1, EZ was normal in 37.6%, patchy in 48.1%, and absent in 14.3%. EZ was measurable in 48.7% with a mean area of 0.07 ± 0.16 mm2. Mean VALS was better in eyes without an EZ defect compared to eyes with an EZ defect (P < 0.0001 at all visits). EZ defect at month 1 was associated with poorer VALS at all follow-up visits (P < 0.0001). Both qualitative and quantitative assessments of EZ status strongly correlated with VALS. Absence of EZ was associated with poorer VALS at both corresponding and future visits, with larger areas of EZ loss associated with worse VALS. Assessment of EZ can be used to identify patients with potentially poor response in eyes with retinal vein occlusion.

Identifiants

pubmed: 34003964
pii: 2772433
doi: 10.1167/tvst.10.3.31
pmc: PMC7998009
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Subventions

Organisme : NEI NIH HHS
ID : U10 EY023521
Pays : United States

Références

Ophthalmology. 2010 Jun;117(6):1124-1133.e1
pubmed: 20381871
PLoS One. 2020 Apr 30;15(4):e0232494
pubmed: 32353052
Bioinformatics. 2017 Aug 1;33(15):2424-2426
pubmed: 28369169
Retina. 2018 Mar;38(3):445-461
pubmed: 29210936
Retina. 2017 Sep;37(9):1710-1722
pubmed: 27984548
Retina. 2008 Nov-Dec;28(10):1502-8
pubmed: 18997611
Br J Ophthalmol. 2007 Dec;91(12):1644-9
pubmed: 17504858
PLoS One. 2013 Dec 26;8(12):e82922
pubmed: 24386127
Ophthalmol Retina. 2020 Jan;4(1):67-76
pubmed: 31669329
Clin Ophthalmol. 2011;5:299-305
pubmed: 21468337
Am J Ophthalmol. 2017 Oct;182:160-167
pubmed: 28837790
Ophthalmol Retina. 2018 Aug;2(8):836-841
pubmed: 30221215
PLoS One. 2018 Jun 20;13(6):e0199552
pubmed: 29924853
Retina. 2011 Sep;31(8):1609-19
pubmed: 21844839
JAMA. 2017 May 23;317(20):2072-2087
pubmed: 28492910
Trans Am Ophthalmol Soc. 2000;98:133-41; discussion 141-3
pubmed: 11190017
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Ophthalmology. 2017 Feb;124(2):245-256
pubmed: 27863843
Ophthalmology. 2010 Jun;117(6):1094-1101.e5
pubmed: 20430447
Clin Ophthalmol. 2016 Jul 18;10:1305-13
pubmed: 27486302
Acta Ophthalmol. 2011 Feb;89(1):e35-40
pubmed: 21155986
Br J Ophthalmol. 2013 Mar;97(3):278-84
pubmed: 23298885
Ophthalmol Retina. 2019 Jan;3(1):83-92
pubmed: 30929820
Retina. 2016 Dec;36(12):2290-2296
pubmed: 27341665
Arch Ophthalmol. 1996 Oct;114(10):1243-7
pubmed: 8859084
Ophthalmology. 2010 Jun;117(6):1102-1112.e1
pubmed: 20398941
Retina. 2020 Apr;40(4):773-785
pubmed: 30640282
Ophthalmology. 2012 May;119(5):1024-32
pubmed: 22440275
Retina. 2018 Mar;38(3):559-568
pubmed: 28248827
Ophthalmology. 2010 Jun;117(6):1113-1123.e15
pubmed: 20430446

Auteurs

Tyler Etheridge (T)

Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Ellen T A Dobson (ETA)

Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin-Madison, Madison, WI, USA.

Marcel Wiedenmann (M)

KNIME GmbH, Konstanz, Germany.

Neal Oden (N)

The Emmes Company, LLC, Rockville, MD, USA.

Paul VanVeldhuisen (P)

The Emmes Company, LLC, Rockville, MD, USA.

Ingrid U Scott (IU)

Departments of Ophthalmology and Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.

Michael S Ip (MS)

Doheny Eye Institute, University of California Los Angeles Stein Eye Institute, Los Angeles, CA, USA.

Kevin W Eliceiri (KW)

Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin-Madison, Madison, WI, USA.
McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.
Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA.

Barbara A Blodi (BA)

Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.

Amitha Domalpally (A)

Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH